Price at Close
Change:
Volume:
×
Buy Stock
Remote Buying of Actinium Pharmaceuticals Inc through IEX is under development on ETFS.com.
Notify Me when it is ready×
Sell Stock
Remote Selling of Actinium Pharmaceuticals Inc through IEX is under development on ETFS.com.
Notify Me when it is ready- Open
- Previous Close
- Bid
- Ask
- Day Range -
- 52 Week Range -
- Volume
- Avg. Volume
- Volume to USD
- Market Cap
- Beta
- PE Ratio
- Latest EPS
- EPS TTM
- Dividend
- Dividend Yield
- Ex-Dividend Date
- Revenue TTM
- Revenue per Share
- Revenue per Employee
- Profit Margin
- Gross Profit TTM
- Total Cash TTM
- Total Debt TTM
Share Distribution
- Shares Outstanding
- Float
- Short Interest
- Short Ratio
- Insider Ownership
- Institution Ownership
Latest Headlines
Sumitomo Mitsui DS Asset Management Company Ltd Acquires 24,548 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI) via ETF Daily News
Manning & Napier Group LLC Trims Stake in Community Healthcare Trust Incorporated (NYSE:CHCT) via ETF Daily News
Manning & Napier Group LLC Lowers Stock Holdings in Healthcare Trust of America, Inc. (NYSE:HTA) via ETF Daily News
Tenet Healthcare stock price target cut to $63 from $103 at Mizuho via MarketWatch
PFG Advisors Takes $247,000 Position in Omega Healthcare Investors, Inc. (NYSE:OHI) via ETF Daily News
Spire Healthcare Group (LON:SPI) Price Target Cut to GBX 237 by Analysts at JPMorgan Chase & Co. via ETF Daily News
Spire Healthcare Group (LON:SPI) Receives “Buy” Rating from Berenberg Bank via ETF Daily News
Creative Financial Designs Inc. ADV Purchases Shares of 328 Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP) via ETF Daily News
Samantha Pearce Sells 8,508 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Stock via ETF Daily News
HC Wainwright Reiterates Buy Rating for Verrica Pharmaceuticals (NASDAQ:VRCA) via ETF Daily News
Actinium Pharmaceuticals Inc Performance
Active Alerts for IEX:ATNM
You don't have any alerts set for IEX:ATNM.
About Actinium Pharmaceuticals Inc
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. The company's product portfolio includes Iomab-B and Actimab-A.
Real-time ATNM to USD Trade Analysis on IEX
Market Status Closed
Analysis is available when the exchange & market are open.